Casabronstein méier resultado

Kaplan-Meier analysis of clinical outcomes in critical COVID-19

Por um escritor misterioso
Last updated 10 novembro 2024
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Tocilizumab in Hospitalized Patients with Severe Covid-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Survival in adult inpatients with COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Survival analysis of all critically ill patients with COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Impact of high neutrophil‐to‐lymphocyte ratio on survival in
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Comparison of clinical characteristics of COVID-19 between elderly
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Survival analysis of all critically ill patients with COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Frontiers Intravenous Immunoglobulin Therapy for Critically Ill
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Learning accurate personalized survival models for predicting
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
COVID, Free Full-Text
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia
Recomendado para você
você pode gostar

© 2014-2024 galemiami.com. All rights reserved.